Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis

Dysfunction of the blood-brain barrier (BBB) is a primary characteristic of experimental autoimmune encephalomyelitis (EAE), an experimental model of multiple sclerosis (MS). Matrine (MAT), a quinolizidine alkaloid derived from the herb Radix Sophorae Flave, has been recently found to suppress clini...

Full description

Saved in:
Bibliographic Details
Main Authors: Su Zhang, Quan-Cheng Kan, Yuming Xu, Guang-Xian Zhang, Lin Zhu
Format: Article
Language:English
Published: Wiley 2013-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/2013/736085
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566667255742464
author Su Zhang
Quan-Cheng Kan
Yuming Xu
Guang-Xian Zhang
Lin Zhu
author_facet Su Zhang
Quan-Cheng Kan
Yuming Xu
Guang-Xian Zhang
Lin Zhu
author_sort Su Zhang
collection DOAJ
description Dysfunction of the blood-brain barrier (BBB) is a primary characteristic of experimental autoimmune encephalomyelitis (EAE), an experimental model of multiple sclerosis (MS). Matrine (MAT), a quinolizidine alkaloid derived from the herb Radix Sophorae Flave, has been recently found to suppress clinical EAE and CNS inflammation. However, whether this effect of MAT is through protecting the integrity and function of the BBB is not known. In the present study, we show that MAT treatment had a therapeutic effect comparable to dexamethasone (DEX) in EAE rats, with reduced Evans Blue extravasation, increased expression of collagen IV, the major component of the basement membrane, and the structure of tight junction (TJ) adaptor protein Zonula occludens-1 (ZO-1). Furthermore, MAT treatment attenuated expression of matrix metalloproteinase-9 and -2 (MMP-9/-2), while it increased the expression of tissue inhibitors of metalloproteinase-1 and -2 (TIMP-1/-2). Our findings demonstrate that MAT reduces BBB leakage by strengthening basement membrane, inhibiting activities of MMP-2 and -9, and upregulating their inhibitors. Taken together, our results identify a novel mechanism underlying the effect of MAT, a natural compound that could be a novel therapy for MS.
format Article
id doaj-art-2d5504fe6cdb4f7693d34d0cbcaa3951
institution Kabale University
issn 0962-9351
1466-1861
language English
publishDate 2013-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-2d5504fe6cdb4f7693d34d0cbcaa39512025-02-03T01:03:30ZengWileyMediators of Inflammation0962-93511466-18612013-01-01201310.1155/2013/736085736085Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune EncephalomyelitisSu Zhang0Quan-Cheng Kan1Yuming Xu2Guang-Xian Zhang3Lin Zhu4Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, ChinaDepartment of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, ChinaDepartment of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, ChinaDepartment of Neurology, Thomas Jefferson University, Philadelphia, PA 19107, USADepartment of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, Henan, ChinaDysfunction of the blood-brain barrier (BBB) is a primary characteristic of experimental autoimmune encephalomyelitis (EAE), an experimental model of multiple sclerosis (MS). Matrine (MAT), a quinolizidine alkaloid derived from the herb Radix Sophorae Flave, has been recently found to suppress clinical EAE and CNS inflammation. However, whether this effect of MAT is through protecting the integrity and function of the BBB is not known. In the present study, we show that MAT treatment had a therapeutic effect comparable to dexamethasone (DEX) in EAE rats, with reduced Evans Blue extravasation, increased expression of collagen IV, the major component of the basement membrane, and the structure of tight junction (TJ) adaptor protein Zonula occludens-1 (ZO-1). Furthermore, MAT treatment attenuated expression of matrix metalloproteinase-9 and -2 (MMP-9/-2), while it increased the expression of tissue inhibitors of metalloproteinase-1 and -2 (TIMP-1/-2). Our findings demonstrate that MAT reduces BBB leakage by strengthening basement membrane, inhibiting activities of MMP-2 and -9, and upregulating their inhibitors. Taken together, our results identify a novel mechanism underlying the effect of MAT, a natural compound that could be a novel therapy for MS.http://dx.doi.org/10.1155/2013/736085
spellingShingle Su Zhang
Quan-Cheng Kan
Yuming Xu
Guang-Xian Zhang
Lin Zhu
Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis
Mediators of Inflammation
title Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis
title_full Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis
title_fullStr Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis
title_full_unstemmed Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis
title_short Inhibitory Effect of Matrine on Blood-Brain Barrier Disruption for the Treatment of Experimental Autoimmune Encephalomyelitis
title_sort inhibitory effect of matrine on blood brain barrier disruption for the treatment of experimental autoimmune encephalomyelitis
url http://dx.doi.org/10.1155/2013/736085
work_keys_str_mv AT suzhang inhibitoryeffectofmatrineonbloodbrainbarrierdisruptionforthetreatmentofexperimentalautoimmuneencephalomyelitis
AT quanchengkan inhibitoryeffectofmatrineonbloodbrainbarrierdisruptionforthetreatmentofexperimentalautoimmuneencephalomyelitis
AT yumingxu inhibitoryeffectofmatrineonbloodbrainbarrierdisruptionforthetreatmentofexperimentalautoimmuneencephalomyelitis
AT guangxianzhang inhibitoryeffectofmatrineonbloodbrainbarrierdisruptionforthetreatmentofexperimentalautoimmuneencephalomyelitis
AT linzhu inhibitoryeffectofmatrineonbloodbrainbarrierdisruptionforthetreatmentofexperimentalautoimmuneencephalomyelitis